“…[2,3] Similar to the well-studied polyhydroxypiperidine, indolizidine, pyrrolidine and pyrrolizidine-type iminocyclitols, [4] calystegines exhibit potent glycoside hydrolase (glycosidase) inhibitory properties. Given the broad range of biological events in which glycosidases are involved, inhibitors of these enzymes have potential in therapies that are targeted at, for example, cancer, [5] viral infections, [6] tuberculosis, [7] diabetes [8] and glycosphingolipid storage disorders.…”